| CLIA | Clinical Laboratory Improvement Amendments of 1988 |
| CPE | carbapenemase-producing enterobacteria |
| CRE | carbapenem-resistant enterobacteria |
| EATR | enzyme-assisted target recycling |
| FDA | Food and Drug Administration (United States of America) |
| FIND | Foundation for Innovative New Diagnostics |
| HDA | helicase-dependent amplification |
| HIV/AIDS | human immunodeficiency virus/acquired immunodeficiency syndrome |
| LAMP | loop-mediated amplification |
| LFI | lateral flow immunochromatographic (tests) |
| MCD | microfluidic centripetal (centrifugal) device |
| MIM | Molecular. In Minutes™ |
| MRSA | methicillin-resistant Staphylococcus aureus |
| NASBA | nucleic acid sequence-based amplification |
| PCR | polymerase chain reaction |
| POC | point of care or point-of-care |
| RDT | rapid diagnostic test |
| RPA | recombinase polymerase amplification |
| RT-rtPCR | reverse transcriptase-real-time PCR |
| rtPCR | real-time PCR |
| SDA | strand displacement amplification |
| TB | tuberculosis |
| UPS | uninterruptible power source |
| WHO | World Health Organization |